Rockwell Medical, Inc. provided earnings guidance for the year 2024. For the year, the company expects Net (Product) Sales of $84.0 million to $88.0 million, 5% to 10% increase over $79.8 million in product sales for 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.455 USD | -3.64% | +0.34% | -23.02% |
Apr. 17 | Rockwell Medical Continues to Expand Its Distribution Capabilities in Western United States | CI |
Apr. 04 | Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.02% | 42.73M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Rockwell Medical, Inc. Provides Earnings Guidance for the Year 2024